1,388
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

Anthropometric measures of adiposity as correlates of atherogenic index of plasma in non-obese sedentary Nigerian males

&
Article: 23798 | Received 11 Jan 2014, Accepted 11 Mar 2014, Published online: 03 Apr 2014

References

  • Freedman D, Serdula M, Srinivasan S, Berensen G. Relation of circumferences and skinfold thickness to lipid and insulin concentrations in children and adolescents: the Bogalusa Heart study. Am J Clin Nutr. 1999; 69: 308–17. [PubMed Abstract].
  • Kissebah A. Intra-abdominal fat: is it a major factor in developing diabetes and coronary artery disease?. Diabetes Res Clin Pract. 1996; 30: 25–30.
  • Jee SH, Sull JW, Park J, Lee S-Y, Ohrr H, Guallar E, etal. Body-mass index and mortality in Korean men and women. N Engl J Med. 2006; 355: 779–87.
  • Rexrode KM, Buring JE, Manson JE. Abdominal and total adiposity and risk of coronary heart disease in men. Int J Obes. 2001; 25: 1047–56.
  • Canoy D, Boekholdt SM, Wareham N, Luben R, Welch A, Bingham S, etal. Body fat distribution and risk of coronary heart disease in men and women in the European prospective investigation into cancer and nutrition in Norfolk cohort: a population-based prospective study. Circulation. 2007; 116: 2933–43.
  • Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, etal. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet. 2005; 366: 1640–9.
  • Dobiasova M, Frohlich J, Sedova M, Chenng MC, Brown BG. Cholesterol esterification and atherogenic index of plasma correlate with lipoprotein size and findings on coronary angiography. J Lipid Res. 2011; 52: 566–71.
  • Litwin SE. Which measures of obesity best predict cardiovascular risk?. J Am Coll Cardiol. 2008; 52: 8.
  • Tariq M, Rajab A. Comparative study for atherogenic index of plasma (AIP) in patients with type 1 diabetes mellitus, type 2 diabetes mellitus, beta thalassemia and hypothyroidism. Int J Chem Res. 2012; 2: 1–9.
  • Nwagha UI, Ikepeazu EJ, Ejezie FE, Neboh EE, Maduka IC. Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu, Nigeria. Afr Health Sci. 2010; 10: 248–52.
  • Dobiasova M. Atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitr Lek. 2006; 52: 64–71. [PubMed Abstract].
  • Merrill GF, Friedrichs GS. Plasma lipid concentrations in college students performing self-selected exercise. J Am Coll Nutr. 1990; 9: 226–30.
  • Nemetz PN, Roger VL, Ransom JE, Bailey KR, Edwards WD, Leibson CL. Recent trends in the prevalence of coronary disease: a population-based autopsy study of non-natural deaths. Arch Intern Med. 2008; 68: 264–70.
  • Bowden RG, Lanning BA, Doyle EI, Johnston HM, Slonaker GS. Lipid levels in a cohort of sedentary university students. Internet J Cardiovasc Res. 2005; 2
  • Baecke JAH, Burema J, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982; 36: 936–42.
  • Daussin FN, Zoll J, Dufour SP, Ponsot E, Lonsdorfer-Wolf E, Doutreleau BM, etal. Effects of interval versus continuous training on cardio respiratory and mitochondrial functions relationship to aerobic performance improvements in sedentary subjects. Am J Physiol Regul Integr Comp Physiol. 2008; 295: R264–72.
  • Jackson AS, Pollock ML. Practical assessment of body composition. Phys Sports Med. 1985; 13: 76–90.
  • American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription. 8th ed. 2009; Philadelphia, PA: Lippincott, Williams and Wilkins.
  • Valdez R. A simple model-based index of abdominal adiposity. J Clin Epidemiol. 1991; 44: 955–6.
  • Guerrero-Romero F, Rodríguez-Morán M. Abdominal volume index: an anthropometry-based index for estimation of obesity is strongly related to impaired glucose tolerance and type 2 diabetes mellitus. Arch Med Res. 2003; 34: 428–32.
  • Rajab TMA. Comparative study for atherogenic index of plasma (AIP) in patients with type I diabetes mellitus, Type 2 diabetes mellitus beta thalassemia and hypothyroidism. Int J Chem Res. 2012; 2: 1–9.
  • Tan MH, Johns D, Glazer NB. Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes. Clin Chem. 2004; 50: 1184–8.
  • Cornier M, Despres JP, Davis N, Grossniklaus DA, Klein S, Lamarche B, etal. Assessing adiposity: a scientific statement from the American Heart Association. Circulation. 2011; 124: 1996–2019.
  • Pap D, Colak E, Singh NM, Grubor-Lajsic G, Vickovic S. Lipoproteins and other risk factors for cardiovascular disease in a student population. J Med Biochem. 2013; 32: 140–5.
  • Abraham PA, Kazman JB, Zeno SA, Deuster PA. Obesity and African Americans: physiologic and behavioural pathways. ISRN Obes. 2013; 314295.
  • Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines in cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil. 2007; 14: 1–S113.
  • Minihane AM, Khan S, Talmud PJ, Williams DL, Wright JW, Murphy MC, etal. Lack of association between lipaemia and central adiposity in subjects with an atherogenic lipoprotein phenotype (ALP). Int J Obes. 2000; 24: 1097–106.
  • Alboqai O, Suleiman A, Hourani HA, Obeidat B, Abuirmeileh N, El-Qudah JM, etal. Central adiposity rather than overall obesity influences cardio-metabolic risk factors among adult males in Northern Jordan. Diabetol Croat. 2009; 38: 73–82.